Particulate matter (PM) air pollution is a global environmental health problem that causes 3.7 million premature deaths annually, representing 6.7% of all deaths worldwide. These deaths are largely due to increased acute cardiopulmonary disease including pneumonia. While the mechanisms are not completely understood, alveolar macrophage (AM)-driven lung inflammation plays an important role in PM-induced health effects. To further explore the potential mechanisms in an unbiased fashion, we performed RNAseq in AMs exposed to PM. In addition to NF-?B target genes (e.g., il6), we found immune response gene 1 (Irg1) as one of the top 10 genes induced by PM. Irg1 encodes aconitate decarboxylase 1 (Acod1), a mitochondrial enzyme that catalyzes the synthesis of itaconate. We found that PM-induced Irg1 expression occurred late, after the expression of il6 and other cytokines. As Irg1 protein was expressed, il6 expression declined. Treatment of AMs with itaconate decreased PM-induced il6, while deletion of Irg1 had an opposite effect and further increased PM-induced il6 expression. PM induced a unique metabolic reprogramming in AMs characterized by increased glycolysis and mitochondrial respiration, which is distinct from the effect of LPS (which reduces respiration). PM also induced mitochondrial ROS (mROS) from complex I (CI) via reverse electron transport (RET). Importantly, we found that both increased respiration and RET-driven mROS are required for PM-induced il6 expression. Itaconate inhibited the PM-induced increase in mitochondrial respiration, RET and resultant mROS via inhibition of succinate dehydrogenase (SDH) (CII) in AMs. Treatment with PM or itaconate reduced the inflammatory response (il6 and antiviral response genes) to bacteria, or influenza virus, suggesting that PM, via Irg1/itaconate/SDH inhibition may impair inflammatory response to pathogens. Based on these preliminary data, we hypothesize that PM first increases mitochondrial respiration, RET and mROS, which are required for the inflammatory response, followed by the late expression of Irg1/itaconate, which by inhibiting SDH, reduces mitochondrial respiration, RET, mROS, and suppresses inflammatory response leading to impaired response to pathogens. We will test our hypothesis in three specific aims.
In aim 1, we will determine how increased mitochondrial respiration and Irg1/itaconate regulate PM-induced metabolic changes and transcriptional responses in AMs.
In Aim 2, we will determine whether Irg1/itaconate suppresses the PM-induced transcriptional response by inhibiting reverse electron transport and mROS.
In Aim 3, we will determine whether PM-induced Irg1/itaconate impairs the inflammatory response to subsequent infection. In this first study that explores the effects of PM on metabolism in AMs, concurrent analysis of the changes in metabolism with the transcriptional data will provide us with important knowledge about how metabolism derives the biologic effects induced by PM. Our investigation of how PM-induced Irg1/itaconate suppresses inflammatory response to pathogens has the potential to offer new therapeutic targets to prevent pneumonia induced by PM exposure.

Public Health Relevance

Particulate matter air pollution is a global environmental health problem that causes 3.7 million premature deaths per year worldwide. Although the mechanisms are not completely understood, lung macrophages play an important role in particulate matter-induced heart and lung disease. In this application, we will determine the mechanisms by which particulate matter affects the metabolism of lung macrophages and how the changes in metabolism affect their function and may predispose to pneumonia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES015024-13
Application #
9936391
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Nadadur, Srikanth
Project Start
2006-09-01
Project End
2023-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Mutlu, Ece A; Comba, I??n Y; Cho, Takugo et al. (2018) Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome. Environ Pollut 240:817-830
Hamanaka, Robert B; Mutlu, Gökhan M (2018) Particulate Matter Air Pollution: Effects on the Cardiovascular System. Front Endocrinol (Lausanne) 9:680
Mutlu, Gökhan M; Budinger, G R Scott (2018) Letter by Mutlu and Budinger Regarding Article, ""Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification"". Circulation 137:1203-1204
Wu, David; Woods, Parker S; Duong, Heng T et al. (2018) Role of Cellular Metabolism in Pulmonary Diseases. Am J Respir Cell Mol Biol 59:127-129
Soberanes, Saul; Misharin, Alexander V; Jairaman, Amit et al. (2018) Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis. Cell Metab :
Hamanaka, Robert B; Nigdelioglu, Recep; Meliton, Angelo Y et al. (2018) Inhibition of Phosphoglycerate Dehydrogenase Attenuates Bleomycin-induced Pulmonary Fibrosis. Am J Respir Cell Mol Biol 58:585-593
Wu, David; Huang, Ru-Ting; Hamanaka, Robert B et al. (2017) HIF-1? is required for disturbed flow-induced metabolic reprogramming in human and porcine vascular endothelium. Elife 6:
Wu, David; Hamanaka, Robert B; Fang, Yun et al. (2017) Letter by Wu et al Regarding Article, ""Mechanical Activation of Hypoxia-Inducible Factor 1? Drives Endothelial Dysfunction at Atheroprone Sites"". Arterioscler Thromb Vasc Biol 37:e197-e198
Hamanaka, Robert B; Mutlu, Gökhan M (2017) PFKFB3, a Direct Target of p63, Is Required for Proliferation and Inhibits Differentiation in Epidermal Keratinocytes. J Invest Dermatol 137:1267-1276
Misharin, Alexander V; Morales-Nebreda, Luisa; Reyfman, Paul A et al. (2017) Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med 214:2387-2404

Showing the most recent 10 out of 53 publications